CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $39,368
- in 1 filing
Net +$960,625. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 3 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-11-15 | Haqq Christopher Chief Medical Officer | Sale | −1,604 | $19.95 | $32K | 383,173 |
| 2016-11-15 | Haqq Christopher Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −829 | 3,869 | ||
| 2016-11-15 | Gallagher Carol Giltner Director | Exercise or conversion | +1,549 | 99,377 | ||
| 2016-11-15 | Gallagher Carol Giltner Director | Exercise or conversion | +817 | 100,194 | ||
| 2016-11-15 | Gallagher Carol Giltner Director | Exercise or conversion · Restricted Stock Units | −1,549 | 7,742 | ||
| 2016-11-15 | Gallagher Carol Giltner Director | Exercise or conversion · Restricted Stock Units | −817 | 4,631 | ||
| 2016-11-15 | Fust Matthew K Director | Exercise or conversion | +1,602 | 17,093 | ||
| 2016-11-15 | Fust Matthew K Director | Exercise or conversion · Restricted Stock Units | −1,602 | 8,547 | ||
| 2016-11-15 | Clark Mitchall G. Chief R & QA Officer | Exercise or conversion | +7,212 | 98,182 | ||
| 2016-11-15 | Clark Mitchall G. Chief R & QA Officer | Exercise or conversion · Restricted Stock Unites | −7,212 | 40,865 | ||
| 2016-11-15 | Soffer Gad Chief Operating Officer | Exercise or conversion | +9,615 | 235,282 | ||
| 2016-11-15 | Soffer Gad Chief Operating Officer | Exercise or conversion | +4,146 | 239,428 | ||
| 2016-11-15 | Soffer Gad Chief Operating Officer | Exercise or conversion · Restricted Stock Units | −9,615 | 16,026 | ||
| 2016-11-15 | Soffer Gad Chief Operating Officer | Exercise or conversion · Restricted Stock Units | −4,146 | 19,347 | ||
| 2016-11-14 | Soffer Gad Chief Operating Officer | Sale | −9,582 | $20.55 | $197K | 225,667 |
| 2016-11-11 | MCGRATH JOHN Chief Financial Officer | Sale | −2,500 | $19.37 | $48K | 89,323 |
| 2016-11-10 | MCGRATH JOHN Chief Financial Officer | Sale | −2,500 | $20.30 | $51K | 91,823 |
| 2016-10-27 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,400 | $13.70 | $33K | 396,978 |
| 2016-10-26 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,400 | $13.91 | $33K | 399,378 |
| 2016-10-14 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,400 | $16.01 | $38K | 401,778 |
Page 50 of 71 · 1,403 trades